Single User License
INR 100350
Site License
INR 200700
Corporate User License
INR 301050

Service Tax Additional

select a format

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500


Request a quote
Request a Customized research
Request for Sample Report

Recent Viewed Reports

Why Ken Reasearch?


While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"

Dart NeuroScience LLC-Product Pipeline Review-2015

Dart NeuroScience LLC-Product Pipeline Review-2015

  Request for Sample Report

Executive Summary

Dart NeuroScience LLC-Product Pipeline Review-2015


Global Markets Direct's, 'Dart NeuroScience LLC-Product Pipeline Review-2015', provides an overview of the Dart NeuroScience LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Dart NeuroScience LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Dart NeuroScience LLC including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Dart NeuroScience LLC's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Dart NeuroScience LLC's pipeline products

Reasons To Buy

Evaluate Dart NeuroScience LLC's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Dart NeuroScience LLC in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Dart NeuroScience LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Dart NeuroScience LLC and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Dart NeuroScience LLC

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Dart NeuroScience LLC and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Dart NeuroScience LLC Snapshot 6

Dart NeuroScience LLC Overview 6

Key Information 6

Key Facts 6

Dart NeuroScience LLC-Research and Development Overview 7

Key Therapeutic Areas 7

Dart NeuroScience LLC-Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products-Monotherapy 11

Dart NeuroScience LLC-Pipeline Products Glance 12

Dart NeuroScience LLC-Clinical Stage Pipeline Products 12

Phase II Products/Combination Treatment Modalities 12

Phase I Products/Combination Treatment Modalities 13

Dart NeuroScience LLC-Early Stage Pipeline Products 14

Preclinical Products/Combination Treatment Modalities 14

Discovery Products/Combination Treatment Modalities 15

Dart NeuroScience LLC-Drug Profiles 16

HT-0712 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

HT-3951 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

Small Molecule 1 for Cognitive Impairment 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

Small Molecule 1 to Inhibit GlyT-1 for Memory Impairment 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

Small Molecule 1 to Inhibit PDE4 for Memory Impairment 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

Small Molecule 10 for Cognitive Impairment 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Small Molecule 11 for Cognitive Impairment 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Small Molecule 12 for Cognitive Impairment 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

Small Molecule 2 for Cognitive Impairment 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

Small Molecule 2 to Inhibit Glyt-1 for Memory Impairment 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

Small Molecule 2 to Inhibit PDE4 for Memory Impairment 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

Small Molecule 3 for Cognitive Impairment 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

Small Molecule 4 for Cognitive Impairment 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

Small Molecule 5 for Cognitive Impairment 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

Small Molecule 6 for Cognitive Impairment 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

Small Molecule 7 for Cognitive Impairment 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

Small Molecule 8 for Cognitive Impairment 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

Small Molecule to Inhibit MAO-B for Memory Impairment 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

Small Molecules to Agonize GABAA Receptor for Cognitive Impairment 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

Small Molecules to Antagonize GALR3 for Memory Impairment 35

Product Description 35

Mechanism of Action 35

R&D Progress 35

Dart NeuroScience LLC-Pipeline Analysis 36

Dart NeuroScience LLC-Pipeline Products by Target 36

Dart NeuroScience LLC-Pipeline Products by Route of Administration 37

Dart NeuroScience LLC-Pipeline Products by Molecule Type 38

Dart NeuroScience LLC-Pipeline Products by Mechanism of Action 39

Dart NeuroScience LLC-Recent Pipeline Updates 40

Dart NeuroScience LLC-Dormant Projects 41

Dart NeuroScience LLC-Discontinued Pipeline Products 42

Discontinued Pipeline Product Profiles 42

HT-2678 42

Dart NeuroScience LLC-Locations And Subsidiaries 43

Head Office 43

Appendix 44

Methodology 44

Coverage 44

Secondary Research 44

Primary Research 44

Expert Panel Validation 44

Contact Us 44

Disclaimer 45

List of Tables

Dart NeuroScience LLC, Key Information 6

Dart NeuroScience LLC, Key Facts 6

Dart NeuroScience LLC-Pipeline by Indication, 2015 9

Dart NeuroScience LLC-Pipeline by Stage of Development, 2015 10

Dart NeuroScience LLC-Monotherapy Products in Pipeline, 2015 11

Dart NeuroScience LLC-Phase II, 2015 12

Dart NeuroScience LLC-Phase I, 2015 13

Dart NeuroScience LLC-Preclinical, 2015 14

Dart NeuroScience LLC-Discovery, 2015 15

Dart NeuroScience LLC-Pipeline by Target, 2015 36

Dart NeuroScience LLC-Pipeline by Route of Administration, 2015 37

Dart NeuroScience LLC-Pipeline by Molecule Type, 2015 38

Dart NeuroScience LLC-Pipeline Products by Mechanism of Action, 2015 39

Dart NeuroScience LLC-Recent Pipeline Updates, 2015 40

Dart NeuroScience LLC-Dormant Developmental Projects,2015 41

Dart NeuroScience LLC-Discontinued Pipeline Products, 2015 42

List of Figures

Dart NeuroScience LLC-Pipeline by Top 10 Indication, 2015 8

Dart NeuroScience LLC-Pipeline by Stage of Development, 2015 10

Dart NeuroScience LLC-Monotherapy Products in Pipeline, 2015 11

Dart NeuroScience LLC-Pipeline by Top 10 Target, 2015 36

Dart NeuroScience LLC-Pipeline by Top 10 Molecule Type, 2015 38

Dart NeuroScience LLC-Pipeline Products by Top 10 Mechanism of Action, 2015 39

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Current R&D Portfolio of Dart NeuroScience LLC; Dart NeuroScience LLC - Key Therapeutics; Dart NeuroScience LLC - Pipeline Overview and Promising Molecules; Dart NeuroScience LLC - News; Dart NeuroScience LLC - Latest Updates; Dart NeuroScience LLC - Pipeline; Dart NeuroScience LLC - Discontinued/Dormant Projects

Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204


Company Brochure

Engage with Us

query [@]